These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 13861854)

  • 1. Clinical and experimental studies of relations between cancer and properdin.
    AOKI T; KOZIMA K; AKAI S; MIYAZAWA M
    Acta Med Biol (Niigata); 1961 Dec; 9():195-210. PubMed ID: 13861854
    [No Abstract]   [Full Text] [Related]  

  • 2. [Properdin in its relation to cancer].
    SACERDOTE DE LUSTIG E
    Sem Med; 1961 Sep; 119():937-8. PubMed ID: 14495825
    [No Abstract]   [Full Text] [Related]  

  • 3. INTERACTION OF PROPERDIN SYSTEM WITH TUMOROUS CELLS.
    ORAVEC C
    Neoplasma; 1964; 11():47-50. PubMed ID: 14116773
    [No Abstract]   [Full Text] [Related]  

  • 4. SERUM PROPERDIN IN TUMOR-BEARING MICE. I. COMPARISON WITH NATURAL AND IMMUNE ANTIBODIES.
    SCHWARTZ EE; WINSTEN S
    Cancer Res; 1964 Jun; 24():825-9. PubMed ID: 14190547
    [No Abstract]   [Full Text] [Related]  

  • 5. SERUM PROPERDIN IN TUMOR-BEARING MICE. II. THE INFLUENCE OF TUMORS OF DIFFERENT ORIGIN.
    SCHWARTZ EE; WINSTEN S
    Cancer Res; 1964 Jun; 24():830-4. PubMed ID: 14190548
    [No Abstract]   [Full Text] [Related]  

  • 6. [The properdin level in rats inoculated with Walker tumor].
    VENDRAMINI R; CALAPAJ GG; CALLEGARO A; GALLO E
    Boll Ist Sieroter Milan; 1959; 38():285-92. PubMed ID: 13841662
    [No Abstract]   [Full Text] [Related]  

  • 7. [OBSERVATION ON TUMORAL IMMUNITY IN CONNECTION WITH THE PROPERDIN SYSTEM].
    NAGY IS; ATS M; KOSZORU M; LUST I
    Sangre (Barc); 1964; 17():272-4. PubMed ID: 14218362
    [No Abstract]   [Full Text] [Related]  

  • 8. [PROPERDIN AND CANCER. II. CHANGES IN THE ASPECIFIC DEFENSES OF THE ORGANISM DURING ANTIBLASTIC CHEMOTHERAPY].
    DAMBROSIO F; SAGONE I
    Ann Ostet Ginecol; 1964 Mar; 86():211-46. PubMed ID: 14159238
    [No Abstract]   [Full Text] [Related]  

  • 9. INVESTIGATIONS ON THE IMMUNOLOGICAL REACTIVITY IN HAEMOBLASTOSES. I. PROPERDIN VALUES IN LEUKAEMIAS, MALIGNANT LYMPHOMAS AND MYELOMAS.
    LIBANSKY J; RYBAK M
    Neoplasma; 1963; 10():261-82. PubMed ID: 14049078
    [No Abstract]   [Full Text] [Related]  

  • 10. Investigation of the serum properdin levels in neoplastic diseases determined by the bacteriophage neutralization assay.
    SEKIGUCHI M; ASHIKAWA K; MOTOYA K; ISHIBASHI Y
    Gan; 1962 Jun; 53():129-43. PubMed ID: 13910377
    [No Abstract]   [Full Text] [Related]  

  • 11. [STUDIES ON HOST DEFENSES AGAINST CANCER. 1. ON THE BACTERIOPHAGE NEUTRALIZING ACTIVITY OF SERUMS].
    SEKIGUCHI M
    Arerugi; 1963; 12():348-57. PubMed ID: 14095328
    [No Abstract]   [Full Text] [Related]  

  • 12. [DETERMINATION OF A FACTOR OF NATURAL IMMUNITY IN MALIGNANT NEOPLASMS OF THE UTERUS].
    VATTERONI M
    Quad Clin Ostet Ginecol; 1964 Apr; 19():200-6. PubMed ID: 14186341
    [No Abstract]   [Full Text] [Related]  

  • 13. [ACTION OF IONIZING RADIATION ON THE ASPECIFIC IMMUNITY PICTURE OF SUBJECTS WITH MALIGNANT UTERINE NEOPLASMS].
    VATTERONI M
    Quad Clin Ostet Ginecol; 1964 Apr; 19():216-24. PubMed ID: 14186343
    [No Abstract]   [Full Text] [Related]  

  • 14. [STUDY OF SOME FACTORS OF NATURAL IMMUNITY IN MALIGNANT NEOPLASMS, WITH PARTICULAR REFERENCE TO FEMALE GENITAL LOCALIZATIONS].
    VATTERONI M
    Quad Clin Ostet Ginecol; 1964 Apr; 19():168-77. PubMed ID: 14186338
    [No Abstract]   [Full Text] [Related]  

  • 15. [AUTOGENOUS DEFENSE AGAINST MALIGNANT TUMORS].
    WILKEN H
    Z Arztl Fortbild (Jena); 1964 Mar; 58():253-8. PubMed ID: 14189546
    [No Abstract]   [Full Text] [Related]  

  • 16. The properdin system in tumorous disease. V. Bacteriocidal properties of sera of some species.
    ORAVEC C; HOLOUBEK V
    Neoplasma; 1959; 6(1):3-5. PubMed ID: 13644484
    [No Abstract]   [Full Text] [Related]  

  • 17. [The properdin system in osteoarticular tuberculosis: relations and correlations with the Middlebrook-Dubos hemagglutination test and with cutaneous reactivity to tuberculin].
    PINAMONTI F; CANE P
    Boll Ist Sieroter Milan; 1961; 40():47-51. PubMed ID: 13735797
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of Zymosan on the properdin level of tumor patients].
    NAGY S; HARTAI F
    Acta Biol Med Ger; 1961; 6():99-102. PubMed ID: 13727492
    [No Abstract]   [Full Text] [Related]  

  • 19. [The "properdin system" and some stomatological diseases. VII. Relation between the serum properdin titer and malignant connective tissue neoplasms of the oral cavity. (Experimental contribution)].
    NITTI G; PETINI PL
    Boll Soc Ital Biol Sper; 1962 Jul; 38():659-61. PubMed ID: 14480070
    [No Abstract]   [Full Text] [Related]  

  • 20. The properdin system in tumorous disease. Part VI. Influence of the properdin fraction on the cancerogenic activity of chicken tumour virus B77.
    SMIDA J; HOLUBEK V; ORAVEC C; THURZO V
    Neoplasma; 1960; 7():26-30. PubMed ID: 13831804
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.